Dr. Alexander Fedotov, PhD is a Director in Enterprise AI at AstraZeneca, where he focuses on applying and scaling multimodal AI models and agentic workflows across the precision health ecosystem. He has nearly two decades of experience at the intersection of precision medicine, AI/ML, and digital health, spanning enterprise data platforms, interoperability frameworks, and clinical risk-assessment engines. Previously, he led the development and deployment of AI-powered precision medicine platforms at Columbia University Medical Center/NewYork-Presbyterian Hospital, established strategic partnerships across the healthcare, biopharmaceutical, diagnostics, and technology ecosystems, and held a product leadership role in an early-stage digital health company. Dr. Fedotov holds a PhD in genetics and molecular biology from Emory University.